Kennondale Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$610K	Sell	95,165 -107,578	-53%	-$690K	0.62%	62
2025 Q1	$718K	Buy	202,743 +68,298	+51%	+$242K	0.78%	50
2024 Q4	$508K	Buy	+134,445	New	+$508K	0.55%	66